It Also raises execution risk because new builds will have to recruit and train scarce system engineers. If FDA anticipations tighten for knowledge integrity, Merck's scale and top quality techniques must aid secure continuity. A downside scenario is slower ramp timing that forces increased dependence on external drug substance associates. https://www.tjcy.com/industry-information/what-is-the-difference-between-generic-and-branded-apis.html